Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Neuromuscular denervation and deafferentation but not motor neuron death are disease features in the Smn2B/- mouse model of SMA.

Tytuł:
Neuromuscular denervation and deafferentation but not motor neuron death are disease features in the Smn2B/- mouse model of SMA.
Autorzy:
Carlini MJ; Center for Motor Neuron Biology and Disease, Columbia University, New York, NY, United States of America.; Department of Neurology, Columbia University, New York, NY, United States of America.
Triplett MK; Center for Motor Neuron Biology and Disease, Columbia University, New York, NY, United States of America.; Department of Neurology, Columbia University, New York, NY, United States of America.
Pellizzoni L; Center for Motor Neuron Biology and Disease, Columbia University, New York, NY, United States of America.; Department of Neurology, Columbia University, New York, NY, United States of America.; Department of Pathology and Cell Biology, Columbia University, New York, NY, United States of America.
Źródło:
PloS one [PLoS One] 2022 Aug 01; Vol. 17 (8), pp. e0267990. Date of Electronic Publication: 2022 Aug 01 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
Język:
English
Imprint Name(s):
Original Publication: San Francisco, CA : Public Library of Science
MeSH Terms:
Muscular Atrophy, Spinal*/pathology
Neurodegenerative Diseases*/pathology
Animals ; Cell Death ; Denervation ; Disease Models, Animal ; Mice ; Mice, Inbred Strains ; Motor Neurons/metabolism ; Survival of Motor Neuron 2 Protein
References:
Prog Brain Res. 2004;143:57-66. (PMID: 14653151)
N Engl J Med. 2021 Mar 11;384(10):915-923. (PMID: 33626251)
Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9920-5. (PMID: 9275227)
Neuromuscul Disord. 2012 Mar;22(3):263-76. (PMID: 22071333)
J Neuropathol Exp Neurol. 2018 Jul 1;77(7):577-597. (PMID: 29767748)
Exp Neurol. 2021 Mar;337:113587. (PMID: 33382987)
Hum Mol Genet. 2017 Jul 1;26(13):2377-2385. (PMID: 28379354)
Neural Plast. 2005;12(2-3):131-9; discussion 263-72. (PMID: 16097481)
Brain. 2019 Jan 1;143(1):69-93. (PMID: 31828288)
Acta Neuropathol Commun. 2015 Sep 15;3:55. (PMID: 26374403)
Hum Mol Genet. 2005 Mar 15;14(6):845-57. (PMID: 15703193)
Hum Mol Genet. 2008 Apr 1;17(7):949-62. (PMID: 18065780)
Cell Rep. 2019 Dec 3;29(10):3087-3100.e7. (PMID: 31801075)
iScience. 2021 Oct 30;24(11):103376. (PMID: 34825141)
Nat Neurosci. 2021 Jul;24(7):930-940. (PMID: 33795885)
J Neurosci. 2012 Jun 20;32(25):8703-15. (PMID: 22723710)
Genes Dev. 2018 Aug 1;32(15-16):1045-1059. (PMID: 30012555)
N Engl J Med. 2018 Feb 15;378(7):625-635. (PMID: 29443664)
Annu Rev Genomics Hum Genet. 2020 Aug 31;21:231-261. (PMID: 32004094)
PLoS One. 2016 Apr 28;11(4):e0154723. (PMID: 27124114)
Nat Rev Neurol. 2020 Dec;16(12):706-715. (PMID: 33057172)
Int J Mol Sci. 2021 Jul 27;22(15):. (PMID: 34360794)
Neuromuscul Disord. 2009 Jan;19(1):69-73. (PMID: 18951794)
Lancet. 2017 Dec 17;388(10063):3017-3026. (PMID: 27939059)
Cell. 1995 Jan 13;80(1):155-65. (PMID: 7813012)
N Engl J Med. 2017 Nov 2;377(18):1713-1722. (PMID: 29091557)
F1000Prime Rep. 2015 Jan 05;7:04. (PMID: 25705387)
J Neurosci. 2006 Aug 23;26(34):8774-86. (PMID: 16928866)
N Engl J Med. 2017 Nov 2;377(18):1723-1732. (PMID: 29091570)
Hum Mol Genet. 2015 Dec 15;24(24):6986-7004. (PMID: 26423457)
Cell Death Dis. 2019 Jul 4;10(7):515. (PMID: 31273192)
Hum Mol Genet. 2016 Oct 15;25(20):4494-4506. (PMID: 28172892)
Hum Mol Genet. 2000 Feb 12;9(3):333-9. (PMID: 10655541)
N Engl J Med. 2021 Jul 29;385(5):427-435. (PMID: 34320287)
Nat Neurosci. 2017 Jul;20(7):905-916. (PMID: 28504671)
Neurobiol Dis. 2013 Jan;49:57-67. (PMID: 22960106)
Cell. 2012 Oct 12;151(2):440-54. (PMID: 23063131)
Neuron. 2011 Feb 10;69(3):453-67. (PMID: 21315257)
Cell Rep Med. 2021 Jul 21;2(7):100346. (PMID: 34337562)
Nature. 2011 Oct 05;478(7367):123-6. (PMID: 21979052)
PLoS One. 2010 Nov 11;5(11):e15457. (PMID: 21085654)
Mol Cell Biol. 2012 Jan;32(1):126-38. (PMID: 22037760)
Hum Mol Genet. 2013 Apr 1;22(7):1328-47. (PMID: 23263861)
Sci Transl Med. 2021 Jan 27;13(578):. (PMID: 33504650)
Cell Rep. 2019 Dec 17;29(12):3885-3901.e5. (PMID: 31851921)
JCI Insight. 2020 Jun 18;5(12):. (PMID: 32516136)
Nat Genet. 2000 Jan;24(1):66-70. (PMID: 10615130)
Nat Biotechnol. 2010 Mar;28(3):271-4. (PMID: 20190738)
Proc Natl Acad Sci U S A. 2021 May 4;118(18):. (PMID: 33931501)
Nat Chem Biol. 2015 Jul;11(7):511-7. (PMID: 26030728)
J Neurosci. 2015 Apr 15;35(15):6038-50. (PMID: 25878277)
J Neurosci. 2015 Jun 10;35(23):8691-700. (PMID: 26063904)
Science. 2014 Aug 8;345(6197):688-93. (PMID: 25104390)
Brain. 2018 Oct 1;141(10):2878-2894. (PMID: 30239612)
Proc Natl Acad Sci U S A. 1999 May 25;96(11):6307-11. (PMID: 10339583)
PLoS Biol. 2020 Jul 14;18(7):e3000410. (PMID: 32663219)
Hum Mol Genet. 2012 Jan 1;21(1):185-95. (PMID: 21968514)
Cell Rep. 2017 Dec 26;21(13):3767-3780. (PMID: 29281826)
Grant Information:
R01 NS102451 United States NS NINDS NIH HHS; R01 NS114218 United States NS NINDS NIH HHS; R01 NS116400 United States NS NINDS NIH HHS
Substance Nomenclature:
0 (SMN2 protein, mouse)
0 (Survival of Motor Neuron 2 Protein)
Entry Date(s):
Date Created: 20220801 Date Completed: 20220803 Latest Revision: 20220822
Update Code:
20240105
PubMed Central ID:
PMC9342749
DOI:
10.1371/journal.pone.0267990
PMID:
35913953
Czasopismo naukowe
Spinal muscular atrophy (SMA) is a neurodegenerative disease characterized by loss of motor neurons and skeletal muscle atrophy which is caused by ubiquitous deficiency in the survival motor neuron (SMN) protein. Several cellular defects contribute to sensory-motor circuit pathology in SMA mice, but the underlying mechanisms have often been studied in one mouse model without validation in other available models. Here, we used Smn2B/- mice to investigate specific behavioral, morphological, and functional aspects of SMA pathology that we previously characterized in the SMNΔ7 model. Smn2B/- SMA mice on a pure FVB/N background display deficits in body weight gain and muscle strength with onset in the second postnatal week and median survival of 19 days. Morphological analysis revealed severe loss of proprioceptive synapses on the soma of motor neurons and prominent denervation of neuromuscular junctions (NMJs) in axial but not distal muscles. In contrast, no evidence of cell death emerged from analysis of several distinct pools of lumbar motor neurons known to be lost in the disease. Moreover, SMA motor neurons from Smn2B/- mice showed robust nuclear accumulation of p53 but lack of phosphorylation of serine 18 at its amino-terminal, which selectively marks degenerating motor neurons in the SMNΔ7 mouse model. These results indicate that NMJ denervation and deafferentation, but not motor neuron death, are conserved features of SMA pathology in Smn2B/- mice.
Competing Interests: The authors have declared that no competing interests exist.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies